NCT04915586View on ClinicalTrials.gov

Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Loculated Empyema
Interventions
DRUG

Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg

Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg for total 3 doses within 24 hours

Trial Locations (1)

56000

University Kebangsaan Malaysia Medical Centre, Cheras

All Listed Sponsors
lead

National University of Malaysia

OTHER

NCT04915586 - Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management | Biotech Hunter | Biotech Hunter